scholarly journals 510 Giant left atrial appendage aneurysm in a 47 years old male: a case report

2021 ◽  
Vol 23 (Supplement_G) ◽  
Author(s):  
Francesca Coraducci ◽  
Sara Belleggia ◽  
Lorenzo Torselletti ◽  
Francesca Coretti ◽  
Yari Valeri ◽  
...  

Abstract Aims Left atrial appendage aneurysm (LAAA) is a rare condition mostly due to congenital malformations or secondary causes. Methods and results Since very few cases are described in the literature, there is uncertainty in treatment and prognosis. Diagnosis is achieved by advanced imaging as transesophageal echocardiography (TEE), which also allows the detection of thrombus, moreover cardiac magnetic resonance (CMR) could be more specific in describing sizes and relationships with surrounding anatomical structures. Surgical aneurysmectomy could be indicated in the majority of cases, especially if compression of other cardiac chambers or mediastinal structures are present. Medical therapy can include tromboprophylaxys and arrhythmias management. Since high quality evidence is scarce, a shared decision making by Heart Team approach should be considered. We present the case of a 47 years old male who came to our attention for palpitations and epigastric pain. The ECG showed high ventricular rate atrial fibrillation (AF) with wide QRS (left bundle branch block morphology). Due to haemodynamic instability the patient underwent urgent electrical cardioversion and coronary angiography showed patent coronary arteries. He had a giant left auricle appendage diagnosed twelve years before and was on antiarrhythmic prophylaxis for previous AF episodes. A TEE was performed and confirmed the diagnosis of LAAA also showing hypokinetic anterior-apical wall due to the interplay with the giant aneurysm. Subsequent CMR showed no LGE and confirmed the absence of thrombus in the LAAA. After Heart Team consultation surgical treatment was proposed to the patient who refused any invasive procedure. Therefore medical treatment was achieved by direct oral anticoagulation and antiarrhythmic therapy with betablockers and flecainide per os. Moreover, a loop recorder for longitudinal monitoring was implanted. At 6 months of follow-up the patient was asymptomatic except for a brief paroxysm of self-limited AF. 510 Figure 1CMR scan showing giant left atrial appendage aneurysm. (A) Transversal view. (B) Frontal view. (C) Sagittal view.510 Figure 2TOE mid oesophageal 57° showing giant left atrial appendage.

2021 ◽  
Vol 11 (1) ◽  
pp. 176
Author(s):  
Stefano Branzoli ◽  
Fabrizio Guarracini ◽  
Massimiliano Marini ◽  
Giovanni D’Onghia ◽  
Daniele Penzo ◽  
...  

Background and Purpose: Left atrial appendage occlusion (LAAO) is an accepted therapeutic option for stroke prevention; however, the ideal technique and device have not yet been identified. In this study we evaluate the potential role of a heart team approach for patients contraindicated for oral anticoagulants and indicated for left atrial appendage closure, to minimize risk and optimize benefit in a patient-centered decision-making process. Methods: Forty patients were evaluated by the heart team for appendage occlusion. Variables considered were CHA2DS2VASc, HASBLED, documented blood transfusions, comorbidities, event forcing anticoagulant interruption, past medical history, anatomy of the left atrial appendage, and patient quality of life. Twenty patients had their appendage occluded percutaneously (65% male, mean age 72.3 ± 7.5, mean CHA2DS2VASc 4.2 ± 1.5, mean HASBLED 3.5 ± 1.1). The other twenty underwent thoracoscopic occlusion (65% male, mean age of 74.9 ± 8, mean CHA2DS2VASc 6.0 ± 1.5, HASBLED mean 5.4 ± 1.4). Percutaneous patients were on dual antiplatelet therapy for the first three months and aspirin thereafter, whereas the others received no anticoagulant/antiplatelet therapy from the day of surgery. Follow up included TEE, CT scan, and periodical clinical evaluation. Results: Mean duration of procedures and hospital stay were comparable. All patients had complete exclusion of the appendage; at a mean follow up of 33.1 ± 14.1 months, no neurological or hemorrhagic events were reported. Conclusions: A heart team approach may improve the decision-making process for stroke and hemorrhage prevention, where LAAO is a therapeutic option. Percutaneous and thoracoscopic appendage occlusion seem to be comparably safe and effective. An epicardial LAAO could be advisable in patients for whom the risk of bleeding is estimated as being too high for post-procedural antiplatelet therapy.


2021 ◽  
Author(s):  
Takeshi Sasaki ◽  
Yuki Kawasaki ◽  
Yosuke Murakami ◽  
Mitsuhiro Fujino ◽  
Kae Nakamura ◽  
...  

2014 ◽  
Vol 75 (9) ◽  
pp. 2429-2432
Author(s):  
Toshihiko SAKAO ◽  
Naoki ISHIDA ◽  
Shimsuke KAJIWARA ◽  
Kenzo OKADA ◽  
Hidenori KIYOCHI ◽  
...  

2014 ◽  
Vol 30 (3) ◽  
pp. 249-249
Author(s):  
Senthil Kumar Aiyappan ◽  
Upasana Ranga ◽  
Saveetha Veeraiyan

2018 ◽  
Vol 11 (4) ◽  
pp. NP161-NP163
Author(s):  
David J. Brenneman ◽  
Andrew D. Pitkin ◽  
Dipankar Gupta ◽  
Mark S. Bleiweis ◽  
Karl M. Reyes ◽  
...  

We present a four-year-old female with an incidental finding of a congenital left atrial appendage aneurysm who underwent surgical resection with excellent results. This case highlights the importance of multimodal imaging in the diagnosis and characterization of this rare condition.


2014 ◽  
Vol 25 (3) ◽  
pp. 597-599 ◽  
Author(s):  
Abhay Tidake ◽  
Pranil Gangurde ◽  
Ajay Mahajan

AbstractA 20 year-old woman presented with systemic embolisation. On subsequent investigation, she was diagnosed with a congenital left atrial appendage aneurysm. Few case reports are reported in the literature. This cardiac malformation presents a diagnostic challenge in patients with cardiomegaly.


Sign in / Sign up

Export Citation Format

Share Document